ERBB2 and breast carcinoma: In this frame, the studies reporting the vectorization of gold(I) and gold(III) complexes into HER2(+) tumoral cells for potential application in breast cancer therapy are based on the use of antibodies or peptides with high affinity and selectivity towards HER2 as vectors.